Among CMPNs, polycythemia vera (PV) and essential thrombocythemia (ET) present distinctive alterations in iron metabolism and erythropoietin (EPO) levels, reflecting the pathophysiological characteristics of each disease and their impact on erythropoiesis [3, 4]. Here, EPO is linked to acquired polycythemia vera.